We are live on
!
Find out more
LP
LMR Partners Portfolio holdings
AUM
$45.4B
1-Year Est. Return
60.68%
This Fund
S&P 500
This Quarter
Est. Return
+17.46%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$14B
AUM Growth
+$3.28B
(+31%)
Cap. Flow
+$324M
Cap. Flow
% of AUM
2.32%
Top 10 Holdings %
Top 10 Hldgs %
24.44%
Holding
1,743
New
418
Increased
280
Reduced
331
Closed
391
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$176M |
| 2 |
Infosys
INFY
|
+$102M |
| 3 |
K
Kellanova
K
|
+$74.6M |
| 4 |
Amazon
AMZN
|
+$58.6M |
| 5 |
Alibaba
BABA
|
+$52.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$114M |
| 2 |
HDFC Bank
HDB
|
+$97.7M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$55.3M |
| 4 |
Roper Technologies
ROP
|
+$45.7M |
| 5 |
Nutanix
NTNX
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.38% |
| 2 | Financials | 4.13% |
| 3 | Consumer Discretionary | 2.33% |
| 4 | Communication Services | 2.26% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
CALL
Uber
UBER
$134B
| $12.5M | 0.09% |
133,500
-231,300
| -63% | -$19M |
|
202
CALL
Carvana
CVNA
$43.3B
| $12.4M | 0.09% |
184,000
+100,000
| +119% | +$5.48M |
|
|
WLAC
203
DELISTED
Willow Lane Acquisition Corp
WLAC
| $12.3M | 0.09% |
1,200,000
| – | – |
|
|
NPAC
204
New Providence Acquisition Corp III
NPAC
$399M
| $12.2M | 0.09% |
+1,200,000
| New | +$12.4M |
|
205
PUT
Bristol-Myers Squibb
BMY
$127B
| $12.1M | 0.09% |
262,400
+142,400
| +119% | +$6.99M |
|
206
Pfizer
PFE
$140B
| $12.1M | 0.09% |
500,000
-94,467
| -16% | -$2.2M |
|
|
207
PUT
Pfizer
PFE
$140B
| $12.1M | 0.09% |
500,000
| – | – |
|
208
Lumentum
LITE
$59.4B
| $12.1M | 0.09% |
+127,000
| New | +$9.01M |
|
209
CALL
NRG Energy
NRG
$29.8B
| $11.9M | 0.09% |
+74,000
| New | +$9.75M |
|
210
Core Scientific
CORZ
$7.23B
| $11.8M | 0.08% |
690,000
-395,000
| -36% | -$3.95M |
|
|
211
PUT
Carvana
CVNA
$43.3B
| $11.8M | 0.08% |
174,500
-50,000
| -22% | -$2.74M |
|
212
Snowflake
SNOW
$92.9B
| $11.6M | 0.08% |
52,000
+19,928
| +62% | +$3.6M |
|
213
argenx
ARGX
$57.4B
| $11.5M | 0.08% |
20,800
+7,670
| +58% | +$4.45M |
|
214
DoorDash
DASH
$75.3B
| $11.5M | 0.08% |
+46,500
| New | +$9.33M |
|
215
CALL
ExxonMobil
XOM
$651B
| $11.4M | 0.08% |
106,000
+80,700
| +319% | +$8.63M |
|
216
JD.com
JD
$40.8B
| $11.3M | 0.08% |
347,301
+242,688
| +232% | +$8.28M |
|
217
Analog Devices
ADI
$181B
| $11.2M | 0.08% |
47,000
-59,000
| -56% | -$12.3M |
|
|
OYSEU
218
Oyster Enterprises II Acquisition Corp Units
OYSEU
| $11.1M | 0.08% |
+1,100,000
| New | +$11.1M |
|
219
T-Mobile US
TMUS
$193B
| $11.1M | 0.08% |
+46,593
| New | +$11.4M |
|
220
Dynatrace
DT
$12.1B
| $11M | 0.08% |
200,000
-60,000
| -23% | -$3.01M |
|
221
PUT
Palantir
PLTR
$295B
| $11M | 0.08% |
80,700
-94,800
| -54% | -$11.1M |
|
222
CALL
TKO Group
TKO
$13.5B
| $11M | 0.08% |
60,200
-657,400
| -92% | -$106M |
|
223
PUT
Teva Pharmaceuticals
TEVA
$35.9B
| $10.8M | 0.08% |
645,300
| – | – |
|
|
PCAPU
224
ProCap Acquisition Corp Unit
PCAPU
$212M
| $10.7M | 0.08% |
+1,000,000
| New | +$11.1M |
|
225
PUT
MongoDB
MDB
$24B
| $10.5M | 0.08% |
50,200
| – | – |
|
Similar funds
AS
TI
LMR Partners's Q2 2025 Portfolio in Review
As of Q2 2025, LMR Partners held 1,743 positions worth $14B, up 31% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
LMR Partners's Q2 2025 filing shows 418 new, 280 increased, 331 reduced and 391 closed positions. Its largest new stake was Infosys: 5,733,005 shares worth $106M. The largest sale was Intra-Cellular Therapies Inc., an estimated $114M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- LMR Partners's largest Q2 2025 buy was Infosys: 5,733,005 shares worth $106M.
- LMR Partners added most to iShares National Muni Bond ETF in Q2 2025, an estimated $176M increase.
- LMR Partners's biggest Q2 2025 reduction was Roper Technologies, cutting an estimated $45.7M.
- LMR Partners fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $114M.
- LMR Partners's ten largest holdings make up 24% of its $14B portfolio in Q2 2025.
- LMR Partners opened 418 new positions and closed 391 in Q2 2025.
- LMR Partners's portfolio value rose 31% quarter-over-quarter to $14B.
Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.